Serina Therapeutics, Inc.
SERSerina Therapeutics, Inc. (SER) is a biopharmaceutical company focused on developing targeted therapies for rare and severe medical conditions, including hospital-based indications such as opioid-resistant pain. The company aims to leverage its proprietary peptide platform to develop innovative drugs that address unmet medical needs.
$4.00 +0.01 (0.25%)
Company News
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
Serina Therapeutics introduces a comprehensive communications platform to provide transparent updates about its SER-252 Parkinson's disease trial, focusing on patient, clinician, and investor engagement.
